Best Approach to Mild Pap Abnormalities?

Oncology NEWS InternationalOncology NEWS International Vol 6 No 3
Volume 6
Issue 3

BETHESDA, Md--A new NCI study will evaluate three techniques to manage atypical squamous cells of undetermined significance that show up on Pap smears, including their cost effectiveness and acceptability to women.

BETHESDA, Md--A new NCI study will evaluate three techniques to manageatypical squamous cells of undetermined significance that show up on Papsmears, including their cost effectiveness and acceptability to women.

The trial will evaluate colposcopy; repeating Pap smears every six months;and human papillomavirus (HPV) testing as a means to differentiate betweenabnormalities that need immediate colposcopy and those that can best befollowed with repeat Pap tests at six-month intervals.

The study enrollment of 7,200 women with mild Pap test abnormalitiesshould be completed next year. Participants will be followed for threeyears. The study centers are the University of Alabama at Birmingham, Universityof Oklahoma, Magee-Womens Hospital, and the University of Washington.

Related Videos
Experts on multiple myeloma
Experts on multiple myeloma
An expert from Weill Cornell Medicine highlights key clinical data indicating the benefits of radium-223 in the treatment of patients with metastatic castration-resistant prostate cancer.
Experts on GVHD with a patient
Experts on breast cancer
Experts on GVHD with a patient
Experts on breast cancer
The risk of radionuclide exposure to the public reflects one reason urologists need to collaborate with radiation oncologists when administering radiopharmaceuticals to patients with prostate cancer.
Switching out beta emitters for alpha emitters, including radium-223, is one way to improve radiopharmaceutical treatment of prostate cancer, according to an expert from Weill Cornell Medicine.
Data demonstrate the feasibility of automated glomerular filtration rate prediction to decide between partial nephrectomy and radical nephrectomy in kidney cancer, according to an expert from the Cleveland Clinic.
Related Content